Up 118% in 6 months! This volume shocker pharma stock skyrockets 14% despite weak trends on Dalal Street Do you own?

Gland Pharma shares hit 52-week high; jump 7% despite market sell-off | Will rally continue after 93% YTD rise?

LiveMint · Markets 1h ago

Divi's Laboratories shares hit record high rising 84% YTD; buy, sell or hold after Q2 results 2026? Brokerages report

LiveMint · Markets 1h ago

Pearl Global shares hit 52-week high ahead of dividend record date; will the rally continue? Experts' views, target

LiveMint · Markets 1h ago

Indian Shares Subdued After Last Week's Strong Rally

NASDAQ · Markets 1h ago

New Zealand Dollar Climbs as Traders Await Election Result

Dow Jones · Markets 1h ago

Magnite vs. Pinterest: Which Media Stock Is a Better Buy in 2026?

NASDAQ · Markets 1h ago

Palantir vs. Snowflake: The AI Sell-Off Is Exposing a Critical Difference for 2027

NASDAQ · Markets 1h ago

Australian Market Modestly Higher In Mid-market

NASDAQ · Markets 2h ago

Bio-Techne Q1 Profit Down

NASDAQ · Markets 2h ago

Stock to buy: Elara Capital recommends this oil share amid volatility in crude oil prices | Check target, upside

LiveMint · Markets 2h ago